Seeing Is Believing
Theseus Pharmaceuticals's activity chart (see below) currently has 18 price targets and 19 ratings on display.
Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 277.5 days.
Most recent stock forecast was given by ALETHIA YOUNG from CANTOR FITZGERALD on 14-Jul-2023. First documented stock forecast 09-Sep-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Nov-2021
$7
$2.94 (72.41%)
Buy Since 30-Jun-2022
$9
$4.94 (121.67%)
$22
Buy Since 02-Nov-2021
$7
$2.94 (72.41%)
$24
What is THRX (Theseus Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on THRX (Theseus Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on THRX (Theseus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on THRX (Theseus Pharmaceuticals)?
Which analyst is the currently most bullish on THRX (Theseus Pharmaceuticals)?
Which analyst is the currently most reserved on THRX (Theseus Pharmaceuticals)?